INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia.
Enne VI, Stirling S, Barber JA, High J, Russell C, Brealey D, Dhesi Z, Colles A, Singh S, Parker R, Peters M, Cherian BP, Riley P, Dryden M, Simpson R, Patel N, Cassidy J, Martin D, Welters ID, Page V, Kandil H, Tudtud E, Turner D, Horne R, O'Grady J, Swart AM, Livermore DM, Gant V; INHALE WP3 Study Group and Committees.
Enne VI, et al.
Intensive Care Med. 2025 Feb;51(2):272-286. doi: 10.1007/s00134-024-07772-2. Epub 2025 Feb 17.
Intensive Care Med. 2025.
PMID: 39961847
Free PMC article.
Clinical Trial.